89results about How to "Use optimization" patented technology

The invention provides an automatic injection device for providing a subcutaneous injection of a substance into a user, comprising: a housing having an open first end and a second end; a syringe movably disposed in the housing, the syringe including a barrel portion for holding the substance, a hollow needle in fluid communication with the barrel portion for ejecting the substance from the syringe, and a bung for sealing the barrel portion and selectively applying pressure to the substance to force the substance through the hollow needle; a plunger for first moving the syringe towards the first end such that the needle projects from the first end and subsequently applying pressure to the bung, the plunger including a rod connected at a first end to the bung, a compressible expanded central portion and a flange between a second end of the rod and the compressible expanded central portion; and a biasing mechanism for biasing the plunger towards the first open end of the housing, the biasing mechanism disposed about the second end of the rod between the flange and the second end of the housing. The present invention also provides methods and kits for using an automatic injection device, and methods and kits for promoting an automatic injection device comprising a medication based on advantageous properties of the device as compared to a pre-filled syringe. The invention also provides methods and kits for training a recipient on use of the automatic injection device.

An automatic injection device for providing a subcutaneous injection is disclosed. The device includes a syringe movably disposed in a housing and including a barrel portion, a needle and a bung for sealing the barrel portion. The device includes a plunger for moving the syringe towards a first open end of the housing such that the needle projects from the first end, and for subsequently applying pressure to the bung. The plunger includes a rod connected at a first end to the bung, a compressible expanded central portion, and a flange between a second end of the rod and the central portion. The device also includes a biasing mechanism for biasing the plunger towards the first open end of the housing, the biasing mechanism disposed about the second end of the rod between the flange and a second end of the housing.

A process is disclosed for producing with good productivity a cross-linked polyaspartic acid resin having biodegradability and high water absorbency. The process features inclusion of one of the following steps: (a) a polysuccinimide, which has been brought into a dispersed state by a dispersant, and a cross-linking agent are reacted to produce the cross-linked polyaspartic acid resin; (b) imide rings of a cross-linked polysuccinimide are subjected to a hydrolysis reaction while controlling a swelling degree of a resulting gel, whereby the cross-linked polyaspartic acid resin is produced; and (c) a gel of a cross-linked polysuccinimide, which has been obtained by reacting a cross-linking agent to a solution of a polysuccinimide in an organic solvent, is disintegrated to subject imide rings of the cross-linked polysuccinimide to a hydrolysis reaction, so that the cross-linked polyaspartic acid resin is produced. The process may also include one or both of the following steps as needed: (d) a gel of the cross-linked polyaspartic acid resin is washed with water and / or a water-miscible organic solvent; and (e) the polysuccinimide is produced using a basic amino acid as a cross-linking agent.

The present invention is directed towards novel azaindole compounds which bind to the AMP site and are potent FBPase inhibitors. The present invention also is directed towards the clinical use of the novel FBPase inhibitors as a method of treatment or prevention of diseases responsive to lowered blood glucose levels.

A stem cell which is obtainable from the non-embryonic tissue isolated from the dental follicle of tooth or wisdom tooth which are able to differentiate into a periodontal ligament like membrane structure.

Objects of the present invention are to provide a blood purifier package which shows a less increase in the amounts of extracts from the materials of its blood purifier, particularly of its selective permeable separation membranes, attributed to the deterioration of the same materials with time after exposure to a radioactive ray or an electron ray, and which is therefore highly reliable in safety in use for hemocatharsis, and to provide a process for manufacturing the same. The present invention relates to a blood purifier package obtained by packing a blood purifier which comprises selectively permeable separation membranes as a main component, and this blood purifier package is characterized in that the blood purifier is packed and sealed together with an oxygen scavenger in a packaging material capable of shutting out an external air and a water vapor, under a condition of a relative humidity of above 40% RH at 25° C.

A process for the for the preparation of dynamically vulcanized thermoplastic elastomers is described. The process comprises melt processing under high shear conditions A) at least one thermoplastic engineering resin, B) at least one vulcanizable rubber, C) a curing agent or curing agents, and D) at least one additional thermoplastic engineering resin in the form of solid particles having an effective diameter of not less than 0.05 mm, wherein said solid particles D) are added to a molten mass of A), B) before, during or after the addition of C) but prior to substantial completion of the vulcanization of B). The process provides a means to avoid substantial degradation or unwanted cross-linking of the thermoplastic engineering resin and provides a means of controlling the reaction temperature during the curing, vulcanization, or cross-linking of the rubber.

In a method to determine a B0 field map describing the local deviation of a nominal Larmor frequency of a magnetic resonance apparatus, wherein magnetic resonance data are acquired in measurements implemented at two different echo times whose difference forms a dephasing time after an excitation at at least two different dephasing times, and a phase change to be used to determine the B0 field map is determined from a difference of phases measured at different echo times, the phase changes of different dephasing times are evaluated to at least partially reduce an ambiguity due to a Nyquist phase wrapping, by using dephasing times that result as a quotient or, given the use of only two dephasing times, as a product, of a base time and a respective prime number from a group including at least two different prime numbers that are greater than one, and wherein the group is selected depending on a desired dynamic range of the B0 field map and / or a maximum tolerated measurement error for the measurements.

The present invention provides a blood purifier which shows a decreased amount of hydrogen peroxide extracted from its selectively permeable separation membranes, and thus is highly reliable in its safety in use for hemecatharysis. The present invention relates to a blood purifier which comprises selectively permeable separation membranes as a main component and which is characterized in that the amount of hydrogen peroxide which is extracted from the selectively permeable separation membrane removed from the blood purifier after 3 months or longer has passed since the sterilization of the blood purifier by exposure to a radioactive ray and / or an electron ray is not larger than 10 ppm.

The invention relates to a gripping device which has a container picking up device and a closure pick up device for picking up and closing containers. The container pick up device is designed to pick up the container, and the closure pick up device is designed to pick up a closure. The closure pick up device is connected to the container pick up device by means of a connecting element which allows a relative movement between the container pick up device and the closure pick up device to take place in order for the container to be closed with the closure.

The present invention relates to a method for preparing polyolefin that can easily and effectively prepare polyolefin having high molecular weight and various molecular weight distributions, which was difficult to prepare using the existing metallocene catalyst, and polyolefin prepared thereby. The method for preparing polyolefin comprises the step of polymerizing olefin monomers, in the presence of a metallocene supported catalyst wherein a metallocene compound having a specific chemical structure is supported in a carrier, and hydrogen gas.